BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18947298)

  • 1. Biomarkers for prostate cancer.
    Makarov DV; Loeb S; Getzenberg RH; Partin AW
    Annu Rev Med; 2009; 60():139-51. PubMed ID: 18947298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for prostate cancer detection.
    Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
    J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer.
    Bangma CH; Wildhagen MF; Yurdakul G; Schröder FH; Blijenberg BG
    BJU Int; 2004 Apr; 93(6):720-4. PubMed ID: 15049979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for prostate cancer detection.
    Reed AB; Parekh DJ
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen: an updated review.
    So A; Goldenberg L; Gleave ME
    Can J Urol; 2003 Dec; 10(6):2040-50. PubMed ID: 14704108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
    Flaig TW; Nordeen SK; Lucia MS; Harrison GS; Glodé LM
    J Urol; 2007 Apr; 177(4):1229-37. PubMed ID: 17382696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New biomarkers and application of multivariate models for detection of prostate cancer].
    Stephan C; Cammann H; Rittenhouse H; Lein M; Jentzmik F; Schrader M; Deger S; Miller K; Jung K
    Aktuelle Urol; 2009 Aug; 40(4):221-30. PubMed ID: 19634072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.
    Stephan C; Cammann H; Meyer HA; Lein M; Jung K
    Cancer Lett; 2007 Apr; 249(1):18-29. PubMed ID: 17292541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.
    Stephan C; Meyer HA; Paul EM; Kristiansen G; Loening SA; Lein M; Jung K
    Anticancer Res; 2007; 27(4A):1833-6. PubMed ID: 17649780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
    Stephan C; Cammann H; Deger S; Schrader M; Meyer HA; Miller K; Lein M; Jung K
    Urology; 2009 Oct; 74(4):873-7. PubMed ID: 19476981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New markers and multivariate models for prostate cancer detection.
    Stephan C; Rittenhouse H; Cammann H; Lein M; Schrader M; Deger S; Miller K; Jung K
    Anticancer Res; 2009 Jul; 29(7):2589-600. PubMed ID: 19596933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for prostate cancer.
    Leman ES; Getzenberg RH
    J Cell Biochem; 2009 Sep; 108(1):3-9. PubMed ID: 19507229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
    Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY
    Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C; Jung K; Lein M; Diamandis EP
    Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodborne biomolecular markers in prostate cancer development and progression.
    Bok RA; Small EJ
    Nat Rev Cancer; 2002 Dec; 2(12):918-26. PubMed ID: 12459730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.